HelloSpore
HelloSpore
My Account
Shop Now →

🔒 256bit SSL encrypted checkout

Your Cart (0)
🛒
Your cart is empty
Home/Research Hub/Psilocybin vs Escitalopram: A Head-to-Head Depression Trial
VideoClinical Research

Psilocybin vs Escitalopram: A Head-to-Head Depression Trial

How psilocybin compared to a standard antidepressant, escitalopram, in a controlled trial for depression.

psilocybindepressionescitaloprampsychedelic therapyclinical researchpsilocybe cubensis

Source Research Papers

Citations in APA 7 format. All studies were sourced from peer-reviewed journals via Google Scholar.

Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402–1411. https://doi.org/10.1056/NEJMoa2032994

🟢 Strong evidenceSupportive
Bottom line

In a careful head-to-head trial, two psilocybin sessions worked about as well as six weeks of a standard antidepressant — and beat it on several secondary measures — though the single main score wasn't a clear-cut win.

Shop Related Spores

Laboratory-grade Psilocybe cubensis spore syringes for microscopy research.

Golden Teacher Spores →
Back to Research Hub